Alan Dillon (Mayo, Fine Gael) | Oireachtas source

I welcome the witnesses and thank them for all they have done in recent months with regard to Covid. It has been an extremely challenging time for many Departments.

I would like to have an understanding of the position of mergers and acquisitions regarding corporation tax receipts. The year 2019 was probably one of the busiest in terms of biopharmaceutical, life sciences and technology companies. Recently, there was a €46 billion acquisition of Allergan by Abbvie. How does the Department factor that into the receipts? Is it accounted for in the report? What process is used to determine the figures and transactions?